Literature DB >> 29212047

Whole brain neuronal abnormalities in focal epilepsy quantified with proton MR spectroscopy.

Ivan I Kirov1, Ruben Kuzniecky2, Hoby P Hetherington3, Brian J Soher4, Matthew S Davitz5, James S Babb6, Heath R Pardoe7, Jullie W Pan8, Oded Gonen9.   

Abstract

OBJECTIVE: To test the hypothesis that localization-related epilepsy is associated with widespread neuronal dysfunction beyond the ictal focus, reflected by a decrease in patients' global concentration of their proton MR spectroscopy (1H-MRS) observed marker, N-acetyl-aspartate (NAA).
METHODS: Thirteen patients with localization-related epilepsy (7 men, 6 women) 40±13 (mean±standard-deviation)years old, 8.3±13.4years of disease duration; and 14 matched controls, were scanned at 3 T with MRI and whole-brain (WB) 1H MRS. Intracranial fractions of brain volume, gray and white matter (fBV, fGM, fWM) were segmented from the MRI, and global absolute NAA creatine (Cr) and choline (Cho) concentrations were estimated from their WB 1H MRS. These metrics were compared between patients and controls using an unequal variance t test.
RESULTS: Patients' fBV, fGM and fWM: 0.81±0.07, 0.47±0.04, 0.31±0.04 were not different from controls' 0.79±0.05, 0.48±0.04, 0.32±0.02; nor were their Cr and Cho concentrations: 7.1±1.1 and 1.3±0.2 millimolar (mM) versus 7.7±0.7 and 1.4±0.1mM (p>0.05 all). Patients' global NAA concentration: 11.5±1.5 mM, however, was 12% lower than controls' 13.0±0.8mM (p=0.004).
CONCLUSIONS: These findings indicate that neuronal dysfunction in localization-related epilepsy extends globally, beyond the ictal zone, but without atrophy or spectroscopic evidence of other pathology. This suggests a diffuse decline in the neurons' health, rather than their number, early in the disease course. WB 1H-MRS assessment, therefore, may be a useful tool for quantification of global neuronal dysfunction load in epilepsy.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Epilepsy; MR spectroscopy (MRS); N-acetyl-aspartate; Volumetric MRI; Whole brain MRS

Mesh:

Substances:

Year:  2017        PMID: 29212047      PMCID: PMC6411059          DOI: 10.1016/j.eplepsyres.2017.11.017

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  35 in total

1.  Unified segmentation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

2.  Robust fully automated shimming of the human brain for high-field 1H spectroscopic imaging.

Authors:  Hoby P Hetherington; Wen-Jang Chu; Oded Gonen; Jullie W Pan
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

Review 3.  Mitochondria and neuronal activity.

Authors:  Oliver Kann; Richard Kovács
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-08       Impact factor: 4.249

4.  Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy.

Authors:  Benjamin A Cohen; Edmond A Knopp; Henry Rusinek; James S Babb; David Zagzag; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

5.  A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.

Authors:  A Falini; M Bozzali; G Magnani; G Pero; A Gambini; B Benedetti; R Mossini; M Franceschi; G Comi; G Scotti; M Filippi
Journal:  Neuroimage       Date:  2005-07-15       Impact factor: 6.556

6.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

Authors:  M Filippi; M Bozzali; M Rovaris; O Gonen; C Kesavadas; A Ghezzi; V Martinelli; R I Grossman; G Scotti; G Comi; A Falini
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

7.  A subcortical network of dysfunction in TLE measured by magnetic resonance spectroscopy.

Authors:  H P Hetherington; R I Kuzniecky; K Vives; O Devinsky; S Pacia; D Luciano; B Vasquez; S Haut; D D Spencer; J W Pan
Journal:  Neurology       Date:  2007-12-11       Impact factor: 9.910

Review 8.  Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.

Authors:  D J Rigotti; M Inglese; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

9.  Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla.

Authors:  Wafaa Zaaraoui; Lazar Fleysher; Roman Fleysher; Songtao Liu; Brian J Soher; Oded Gonen
Journal:  Magn Reson Med       Date:  2007-06       Impact factor: 4.668

10.  In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.

Authors:  Patrick J Bolan; Sina Meisamy; Eva H Baker; Joseph Lin; Timothy Emory; Michael Nelson; Lenore I Everson; Douglas Yee; Michael Garwood
Journal:  Magn Reson Med       Date:  2003-12       Impact factor: 4.668

View more
  2 in total

Review 1.  Recent Advances in Neuroimaging of Epilepsy.

Authors:  Adam M Goodman; Jerzy P Szaflarski
Journal:  Neurotherapeutics       Date:  2021-05-03       Impact factor: 7.620

2.  Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures.

Authors:  Myriam Abdennadher; Sara Inati; Ariane Soldatos; Gina Norato; Eva H Baker; Audrey Thurm; Luca Bartolini; Ruturaj Masvekar; William Theodore; Bibiana Bielekova; Forbes D Porter; An N Dang Do
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.